SP
Shuttle Pharmaceuticals Holdings, Inc.
SEC filingOther Technology · Gaithersburg, MD
Amount raised$10Msold at filing
Total offering$10M
Investors in the raise47count reported to the SEC
FiledMay 15, 2026first sale Apr 30, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Ryan TrasoliniExecutive Officer
Adam ChambersDirector
Yuying LiangExecutive Officer
George ScorsisDirector
Angel LirianoDirector
Christopher CooperExecutive Officer, Director
Executive officers, directors and promoters as listed on the Form D.